Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A Novel Triple-Action Inhibitor Targeting B-Cell Receptor Signaling and BRD4 Demonstrates Preclinical Activity in Chronic Lymphocytic Leukemia.
Int J Mol Sci. 2022 Jun 16;23(12):6712. doi: 10.3390/ijms23126712.
Int J Mol Sci. 2022.
PMID: 35743155
Free PMC article.
Preclinical activity of a novel multi-axis inhibitor in aggressive and indolent B-cell malignancies.
Smith AL, Pal D, Martinez-Rico R, Eiken AP, Durden DL, Kutateladze TG, El-Gamal D.
Smith AL, et al. Among authors: eiken ap.
Leuk Lymphoma. 2023 Dec;64(14):2333-2337. doi: 10.1080/10428194.2023.2256914. Epub 2023 Sep 14.
Leuk Lymphoma. 2023.
PMID: 37706519
No abstract available.
Item in Clipboard
Novel spirocyclic dimer, SpiD3, targets chronic lymphocytic leukemia survival pathways with potent preclinical effects.
Eiken AP, Smith AL, Skupa SA, Schmitz E, Rana S, Singh S, Kumar S, Mallareddy JR, de Cubas AA, Krishna A, Kalluchi A, Rowley MJ, D'Angelo CR, Lunning MA, Bociek RG, Vose JM, Natarajan A, El-Gamal D.
Eiken AP, et al.
Cancer Res Commun. 2024 Apr 30. doi: 10.1158/2767-9764.CRC-24-0071. Online ahead of print.
Cancer Res Commun. 2024.
PMID: 38687198
Free article.
Item in Clipboard
Editorial for the IJMS Special Issue on Molecular Pathogenesis and Molecular Therapy of Lymphoid Malignancies.
Eiken AP, El-Gamal D.
Eiken AP, et al.
Int J Mol Sci. 2023 Dec 31;25(1):557. doi: 10.3390/ijms25010557.
Int J Mol Sci. 2023.
PMID: 38203728
Free PMC article.
Item in Clipboard
Cite
Cite